Abstract
The main arguments in support of researching anxiety and depression in patients with chronic somatic diseases are the prevalence of affective disorders in the population, somatic conditions as risk factors of affective disorders and the search for effective preventative and therapeutic strategies. The aim of the study was to determine the association between the functional status, selected sociodemographic characteristics and prevalence as well as severity of anxiety and depression in patients with multiple sclerosis (MS), Parkinson’s disease (PD) and history of stroke (S). Material and methods: Eighty participants (44 women and 36 men) with MS (n = 22), PD (n = 31) and history of stroke (n = 27) were enrolled. All participants completed a questionnaire consisting of metrics, the Katz Index of Independence in Activities of Daily Living and the Hospital Anxiety and Depression Scale (HADS). Results: Fifty-five per cent of all participants did not present with anxiety or depression, 20% scored above the diagnostic threshold on the anxiety scale and 26% scored above the diagnostic threshold on the depression scale. Subgroup analysis revealed that anxiety and depression sufferers were 13.64% and 13.64% of MS patients, respectively; 22.58% and 35.48% of PD patients, respectively; and 22.22% and 25.93% of stroke survivors, respectively. There was a significant correlation between depression and independence level in the entire group and between depression and marital status in stroke survivors. Conclusions: Although depression and anxiety are highly prevalent in patients with neurological conditions, the disorder has a very individual nature and is not associated with the patient’s age, duration of a condition or concomitant diseases. Screening for depression and anxiety as a part of comprehensive approach may increase treatment efficacy in neurological patients
Highlights
Out of all neurological conditions, there are three which, owing to their prevalence and social impact, pose a significant population-wide challenge, namely, multiple sclerosis (MS), Parkinson’sMedicina 2020, 56, 117; doi:10.3390/medicina56030117 www.mdpi.com/journal/medicinaMedicina 2020, 56, 117 disease (PD) and stroke (S) [1,2,3]
Participant comparison with sex as a grouping variable yielded no significant differences in age, duration of neurological condition, anxiety, depression and level of independence
Our results demonstrated that affective disorder is highly prevalent in neurological patients, affecting between a fifth to over a quarter of all patients
Summary
Out of all neurological conditions, there are three which, owing to their prevalence and social impact, pose a significant population-wide challenge, namely, multiple sclerosis (MS), Parkinson’s. Medicina 2020, 56, 117 disease (PD) and stroke (S) [1,2,3]. They differ in aetiology, clinical course and affected populations, each of them significantly affects an individual’s level of functional independence in various domains of life. MS is a debilitating condition affecting the younger population and PD affects the elderly, whereas both are chronic and progressive. On the other hand, is an acute condition, yet its sequelae affect an individual throughout the entire lifespan. The response is closely linked to personality- and circumstance-related factors [4]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
